| 摘要 |
Pharmaceutical compositions comprising 1-(furazanyl-3-yl)-[1,2,3]triazole derivatives of the general formula (I) wherein the meanings of R<1>, R<2>, R<3>, R<4>, R<5> and n are as given in the description, for the treatment and/or prevention of disorders and diseases, wherein an inhibition of GSK-3 (glycogen synthase kinase-3) is beneficial, especially Alzheimer's disease, bipolar disorder, IGT (impaired glucose tolerance), Type 1 diabetes, Type 2 diabetes and obesity. |
